欢迎来到OAJRC平台! 英文版

info@oajrc.org
首页 > 精选文章 > 精选文章

International Journal of Internal Medicine. 2020; 1: (1) 3; DOI:10.26855/j.ijim.20200003.

Clinical effect of intracranial vascular intervention in the treatment of ischemic cerebrovascular disease
颅内血管介入治疗缺血性脑血管病的临床效果研究

作者: 程仙送,高俊卿,邸伟,李欢欢*

陕西省人民医院神经内科

空军军医大附属唐都医院神经内科

*通讯作者:李欢欢,单位:空军军医大附属唐都医院神经内科;

引用本文: 程仙送,高俊卿,邸伟,李欢欢. 颅内血管介入治疗缺血性脑血管病的临床效果研究[J]. 国际内科前沿杂志, 2020, 1(1) : 9-12.
Published: 2019-12-05

摘要

目的:对缺血性脑血管病治疗中颅内血管介入治疗的效果进行分析,以期能够为医护人员开展工作提供些许帮助。方法:本次实验选取2018年8月-2019年8月期间本院缺血性脑血管病患者70例,通过抽签将患者分为甲乙两组,两组患者人相同。医护人员对甲组患者实施常规治疗,对乙组患者实施颅内血管介入治疗,统计和记录两组患者短暂性脑缺血出现情况、脑梗塞出现情况及NIHSS评分。结果:研究结果显示,相比甲组患者,乙组患者短暂性脑缺血出现几率较低,两组患者短暂性脑缺血出现几率分别为8.57%及0.00%,两组患者之间存在明显差异,具有统计学意义(p<0.05);乙组患者脑梗塞出现几率明显低于甲组患者,两组患者脑梗塞(一年)出现几率分别为17.14%及2.86%,两组之间差异显著,具有统计学意义(p<0.05);治疗后,相比甲组,乙组患者NIHSS评分较低,两组患者NIHSS评分分别为(8.22±1.36)分及(8.22±1.36)分,两组之间差异较大,具有统计学意义(p<0.05)。在治疗前,甲乙两组患者NIHSS评分分别为(10.97±1.31)分及(10.98±1.30)分,甲乙两组患者NIHSS评分之间不存在明显差异,不具有统计学意义(p>0.05)。结论:颅内血管介入治疗在缺血性脑血管病治疗中有着较好的效果,能够在一定程度上减少缺血性脑血管病患者出现短暂性脑缺血及脑梗塞的情况,降低患者的NIHSS评分,具有一定的现实意义。

关键词: 颅内血管介入治疗;缺血性脑血管病;临床效果

Abstract

Objective: To analyze the effect of intracranial vascular interventional therapy in the treatment of ischemic cerebrovascular disease, in order to provide some help for medical staff to carry out their work.
Methods: In this experiment, 70 patients with ischemic cerebrovascular disease in our hospital were selected from August 2018 to August 2019. The patients were divided into two groups of A and B by drawing lots, and the patients in the two groups were the same. Medical staff performed routine treatment for patients in group A, and intracranial vascular interventional treatment for patients in group B. Statistics and records of the occurrence of transient cerebral ischemia, cerebral infarction, and NIHSS scores were performed in both groups.
Results: The results of the study showed that compared with patients in group A, the incidence of transient cerebral ischemia was lower in group B. The incidence of transient cerebral ischemia in the two groups was 8.57% and 0.00%, respectively. The difference was statistically significant (p <0.05). The incidence of cerebral infarction in group B was significantly lower than that in group A. The incidence of cerebral infarction (one year) in the two groups was 17.14% and 2.86%, respectively. The difference between the two groups Significant and statistically significant (p <0.05). After treatment, compared with group A, patients in group B had lower NIHSS scores. The two groups had NIHSS scores of (8.22 ± 1.36) points and (8.22 ± 1.36) points. The differences between the groups were significant and statistically significant (p <0.05). Before treatment, the NIHSS scores of patients in group A and group B were (10.97 ± 1.31) points and (10.98 ± 1.30) respectively. There was no significant difference in the NIHSS scores of patients in group A and group B, and there was no statistical significance (p> 0.05).
Conclusion: Intracranial vascular interventional therapy has a good effect in the treatment of ischemic cerebrovascular disease. It can reduce the transient cerebral ischemia and cerebral infarction in patients with ischemic cerebrovascular disease to a certain extent, and reduce the The NIHSS score has certain practical significance.

Key words: intracranial vascular interventional therapy; ischemic cerebrovascular disease; clinical effect

参考文献 References

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

  • 181

    总浏览量

浏览了此文章的还浏览了